Impairment of hERG1 function through either gene mutation or pharmacological blockade by diverse drugs in clinical use causes a prolongation of APD, which is mirrored by a prolonged QT interval at the ECG thus increasing the risk of life-threatening arrhythmias (Vandenberg et al., 2012). The gene discussed is KCNH2; the disease is cardiac arrhythmia.